(3aS,8aR)-2-(Pyridin-2-ylmethyl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole, 97%, 100mg

4-Butylbenzene-1,2-diol, 98%, 100mg

(2-Bromo-4-(trifluoromethyl)thiazol-5-yl)methanol, 95+%, 1g

Buffer solution pH 7.00 ±0.01 (20 °C), ROTI®Star, 500 ml, plastic packaging.

(2S,3R)-1-(tert-Butoxycarbonyl)-3-hydroxypyrrolidine-2-carboxylic acid, 95.0%, 50mg

5-Methyl-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine, 98%, 500mg

4-Methyl-3,4-dihydroquinoxalin-2(1H)-one, 95.0%, 1g

6-Benzyloxyindole-3-acetonitrile, 95.0%, 500mg

2-Bromo-6-fluorobenzenesulfonyl chloride, 95.0%, 250mg

Hexyl b-D-glucopyranoside, 95.0%, 100mg

(4-Methylpyridin-3-yl)methanol, 97.0%, 250mg

1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(GC)(T)1g

5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyrazine, 96%, 250mg